This clinical trial is focused on reducing complications after a surgical procedure called a cystectomy, which involves removing the bladder. The study is particularly interested in preventing complications caused by fungal infections. To achieve this, the trial will use a medication called Fluconazole, which is given as a solution through an intravenous infusion. This means the medicine is delivered directly into the bloodstream through a vein. The study will compare the effects of Fluconazole with a placebo to see if it can effectively reduce the risk of complications after surgery.
The main goal of the study is to determine if using Fluconazole as a preventive treatment can help reduce the number of complications that occur after a cystectomy. Participants in the study will receive either Fluconazole or a placebo during their treatment. The study will monitor various outcomes, such as the number of days participants are alive and out of the hospital within 90 days after surgery, the time it takes for their digestive system to start working again, and their overall quality of life. The study will also look at the length of hospital stay, the need for re-admission, and any infections that require treatment.
Throughout the study, participants will be closely monitored to ensure their safety and to gather information on how well the treatment works. The trial is expected to continue until the end of 2026, with recruitment starting in early 2024. This research aims to provide valuable insights into improving recovery and reducing complications for patients undergoing cystectomy.



Denmark